Second death in Novartis gene therapy trials under investigation
Novartis said investigation is underway into whether a second trial death could be related to its experimental gene therapy…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Latest Updates
Ministry of AYUSH in MoU with CSIR
Under the MoU, both the organisations will jointly pursue R&D covering fundamental research
Cipla appoints Dr Raju Mistry as President and GCPO
In her role at Cipla, Mistry will oversee human resources, and administration and facilities management
USFDA gives Alembic Pharma a nod for conjunctivitis treatment drug
The company has received approval from the US Food and Drug Administration (USFDA) for its abbreviated new drug application (ANDA)…
Torrent Pharma recalls 1.7 mn bottles of BP drug from US over quality norms
The company is also recalling 476,340 bottles of Losartan Potassium tablets USP, 50 mg from these markets, USFDA said
Novo Nordisk and Gilead team up to test fatty liver disease treatment
The two pharma firms will run combined clinical trials to treat NASH disease
Lower dose of Pfizer-Lilly painkiller misses main goals in late stage study
A study, being carried out by the companies to test the effectiveness of lower doses of tanezumab for osteoarthritis, reported…
Cipla’s Yusuf Hamied recieves Honorary Fellowship of the Royal Society, UK
Cipla's chairman among the 51 experts elected as Honorary Fellows by the Royal Society of London for the year 2019
Dr Yusuf…
Aurobindo recalls 88k Lidocaine injections from US
The company recalled them due to the presence of a hair strand
Aurobindo Pharma has initiated recall of 88,600 vials of Lidocaine…
Granules India gets USFDA nod for pain relief drug
The US Food and Drug Administration (USFDA) has approved its abbreviated new drug application (ANDA) for Acetaminophen 650 mg…
India to be one of the world’s ‘fastest growing bio’ hubs in 2019: CPhI
India has over 70 approved biosimilars in the domestic market (more than any other country) and market penetration – which is…
Abbott’s Digene offers scientific solution for hyperacidity
61 per cent of the population in urban India suffers from hyperacidity at some point in time, shows new market research. Abbott’s…
Govt invites initial bids for strategic sale of IMPCL
IMPCL is engaged in manufacture and supply of ‘ayurvedic’ and ‘unani’ medicines and is under the Ministry of AYUSH
The Government…
Roche launches Emicizumab for people with Hemophilia A on World Hemophilia Day
It is a first-in-class of treatments for people with severe Hemophilia A, with inhibitors in nearly 20 years
7th DIA IndiaPharmacovigilance Conference held in Mumbai
The two-day conference discussed the latest trends and developments in pharmacovigilance, drug safety and medical affairs and the…
Lloyd Group of Institutions organises Niyukti Job Fest in Noida
More than 1700 students from 230+ institutes/universities registered for the placement drive conducted by 50+ companies
J&J beats estimates on pharma strength, raises sales forecast
Sales from the business rose 4.1 per cent to $10.24 billion, above analysts' average estimate of $9.72 billion, according to three…
Cipla Medpro to acquire 30 per cent stake in Brandmed
Cipla had announced a similar partnership in India with Wellthy Therapeutics to offer a clinically-validated digital disease…
Lupin receives FDA approval for Fluoxetine Tablets USP
Lupin’s Fluoxetine Tablets USP, 10 mg and 20 mg, is the generic version of Eli Lilly’s Prozac Tablets, 10 mg and 20 mg
Lupin…
Hovione Technology announces acquisition of global rights to new pulmonary inhaler device – the…
Papillon DPI is a single-part, blister-based, reusable inhaler of extreme simplicity, suitable for both chronic and acute…